August 24, 2009 -
August 24, 2009 New Intelence Prescribing Information Warns of Severe Rash Risk The prescribing information for Intelence (etravirine) has been updated to reflect warnings of rare ... symptoms and sometimes organ problems, including liver failure. Intelence is a non-nucleoside reverse transcriptase inhibitor approved ... drug s safety or effectiveness. Tibotec, which makes Intelence, said that 1.3 percent of people ...
http://www.aidsmeds.com/articles/hiv_rash_intelence_1667_17143.shtml
July 22, 2009 -
Tim Horn -
... Tim Horn A drug regimen containing Isentress (raltegravir), Intelence (etravirine) and Norvir (ritonavir) boosted Prezista (darunavir) continues to ... Pathogenesis, Treatment and Prevention in Cape Town. Isentress, Intelence and Prezista are three of the newest antiretrovirals ... enrolled 103 HIV-positive patients to take Isentress, Intelence and Norvir-boosted Prezista with an optional background ... conferring at least partial resistance to Prezista and Intelence, respectively. The authors also reported that 59 ...
http://www.aidsmeds.com/articles/hiv_trio_isentress_2351_16955.shtml
July 22, 2009 -
Tim Horn -
... Tim Horn A drug regimen containing Isentress (raltegravir), Intelence (etravirine) and Norvir (ritonavir) boosted Prezista (darunavir) continues to ... Pathogenesis, Treatment and Prevention in Cape Town. Isentress, Intelence and Prezista are three of the newest antiretrovirals ... enrolled 103 HIV-positive patients to take Isentress, Intelence and Norvir-boosted Prezista with an optional background ... conferring at least partial resistance to Prezista and Intelence, respectively. The authors also reported that 59 ...
http://www.aidsmeds.com/articles/hiv_trio_isentress_1667_16955.shtml
April 15, 2009 -
April 15, 2009 Possible Interaction Between Isentress and Intelence? Intelence (etravirine) may lower blood levels of Isentress (raltegravir) in ... the April 27 issue of AIDS. Isentress and Intelence, an integrase inhibitor and a non-nucleoside reverse ... of the cases, the patients started Isentress and Intelence at the same time. In the remaining ...
http://www.aidsmeds.com/articles/hiv_isentress_intelence_1667_16459.shtml
March 31, 2009 -
David Evans -
... click here) for more information Not available Tibotec Intelence (etravirine); Prezista (darunavir) Covers both Tibotec ARVs Call 866 ...
http://www.aidsmeds.com/articles/hiv_pap_copayment_2042_16390.shtml
February 11, 2009 -
Tim Horn -
... of heart attacks. Data for the newest NNRTI, Intelence (etravirine), and the least used NNRTI, Rescriptor (delavirdine), were ...
http://www.aidsmeds.com/articles/hiv_abacavir_kaletra_heart_1667_16091.shtml
February 11, 2009 -
Tim Horn -
... of heart attacks. Data for the newest NNRTI, Intelence (etravirine), and the least used NNRTI, Rescriptor (delavirdine), were ...
http://www.aidsmeds.com/articles/hiv_abacavir_kaletra_heart_2297_16091.shtml
December 30, 2008 -
Tim Horn -
... patient where a good partnership is crucial. Introducing Intelence The year began with excellent news when the FDA approved Tibotec s twice-daily Intelence (etravirine). Not only was it the first new non ... Sustiva (efavirenz). Study results also emerged suggesting that Intelence may be potent enough, used once a day ... for those starting treatment for the first time. Intelence comes with the baggage of hope, says ...
http://www.aidsmeds.com/articles/2008_treatment_review_2042_15852.shtml
November 21, 2008 -
November 21, 2008 Once-Daily Intelence Could Work as First-line Treatment Intelence (etravirine) may be potent enough for once-daily use ... Infection in Glasgow and reported by aidsmap.com. Intelence is currently approved for twice-a-day use ... 40 hours to be eliminated from the body, Intelence is a good candidate for once-a- ...
http://www.aidsmeds.com/articles/hiv_intelence_etravirine_1667_15671.shtml
November 4, 2008 -
David Evans -
... combinations of the newest ARVs including Prezista (darunavir), Intelence (etravirine), Isentress (raltegravir) and Selzentry (maraviroc) are able to ...
http://www.aidsmeds.com/articles/hiv_haart_future_2042_15561.shtml
